Celularity (CELU) Other financing activities (2020 - 2025)
Celularity (CELU) posted quarterly Other financing activities of -$902000.0 for Q3 2025, up 84.82% quarter-over-quarter from -$5.9 million in Q4 2024.
Celularity (CELU) Other financing activities (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Other financing activities for 6 consecutive years, with -$902000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Other financing activities changed N/A year-over-year to -$902000.0; the TTM figure through Dec 2025 stood at -$6.8 million (down 11900.0% YoY), while the FY2025 annual figure was $108000.0, up 86.21% from the prior year.
- Other financing activities improved to -$902000.0 in Q3 2025 per CELU's latest filing, from -$5.9 million in the prior quarter.
- Across five years, Other financing activities topped out at $46.5 million in Q1 2022 and bottomed at -$45.6 million in Q4 2022.
- Historically, Other financing activities has averaged $1.0 million across 5 years, with a median of $300000.0 in 2023.
- On a YoY basis, Other financing activities climbed as much as 7789.95% in 2022 and fell as far as 11094.7% in 2022.
- Celularity's Other financing activities stood at $415000.0 in 2021, then tumbled by 11094.7% to -$45.6 million in 2022, then surged by 127.28% to $12.4 million in 2023, then plunged by 147.74% to -$5.9 million in 2024, then surged by 84.82% to -$902000.0 in 2025.
- Business Quant data shows CELU's Other financing activities at -$902000.0 in Q3 2025, -$5.9 million in Q4 2024, and $6.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Celularity | 19.68 Mn | 13.50 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -902,000.00 |
| Sep 30, 2025 | -902,000.00 |
| Dec 31, 2024 | -5.94 Mn |
| Dec 31, 2024 | -5.94 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | 12.45 Mn |
| Dec 31, 2023 | 12.45 Mn |
| Sep 30, 2023 | -12.45 Mn |
| Sep 30, 2023 | -12.45 Mn |
| Jun 30, 2023 | 12.45 Mn |
| Jun 30, 2023 | 12.45 Mn |
| Mar 31, 2023 | 300,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | -45.63 Mn |
| Dec 31, 2022 | -45.63 Mn |
| Sep 30, 2022 | 16.49 Mn |
| Sep 30, 2022 | 16.49 Mn |
| Jun 30, 2022 | -16.49 Mn |
| Jun 30, 2022 | -16.49 Mn |